Aurora Cannabis Inc (NYSE:ACB) Expected to Earn Q3 2020 Earnings of ($0.01) Per Share

Aurora Cannabis Inc (NYSE:ACB) – Equities research analysts at Seaport Global Securities cut their Q3 2020 earnings per share estimates for shares …

Aurora Cannabis logo

Aurora Cannabis Inc (NYSE:ACB) – Equities research analysts at Seaport Global Securities cut their Q3 2020 earnings per share estimates for shares of Aurora Cannabis in a report released on Tuesday, May 28th, according to Zacks Investment Research. Seaport Global Securities analyst B. Hundley now anticipates that the company will earn ($0.01) per share for the quarter, down from their prior estimate of $0.01. Seaport Global Securities also issued estimates for Aurora Cannabis’ Q4 2020 earnings at $0.01 EPS and FY2021 earnings at $0.04 EPS.

ACB has been the subject of several other research reports. Bank of America started coverage on shares of Aurora Cannabis in a report on Wednesday, April 17th. They issued a “buy” rating and a $11.00 price objective for the company. Desjardins started coverage on shares of Aurora Cannabis in a research report on Thursday, April 25th. They issued a “buy” rating and a $9.07 price target on the stock. Stifel Nicolaus started coverage on shares of Aurora Cannabis in a research report on Wednesday, June 5th. They issued a “hold” rating on the stock. Zacks Investment Research cut shares of Aurora Cannabis from a “hold” rating to a “sell” rating in a research report on Tuesday, May 14th. Finally, TheStreet upgraded shares of Aurora Cannabis from a “d+” rating to a “c” rating in a research report on Thursday, April 4th. Four investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Aurora Cannabis has an average rating of “Buy” and an average target price of $9.86.

ACB stock traded down $0.14 during trading on Wednesday, hitting $7.30. The company had a trading volume of 16,148,900 shares, compared to its average volume of 10,209,622. The company has a market capitalization of $7.54 billion, a P/E ratio of 60.83 and a beta of 2.80. Aurora Cannabis has a fifty-two week low of $4.05 and a fifty-two week high of $12.52. The company has a quick ratio of 1.98, a current ratio of 2.37 and a debt-to-equity ratio of 0.10.

A number of institutional investors have recently modified their holdings of the business. ETF Managers Group LLC acquired a new stake in Aurora Cannabis during the 4th quarter worth about $40,454,000. Norges Bank acquired a new stake in Aurora Cannabis during the 4th quarter worth about $30,915,000. TD Asset Management Inc. acquired a new stake in Aurora Cannabis during the 4th quarter worth about $16,657,000. JW Asset Management LLC acquired a new stake in Aurora Cannabis during the 4th quarter worth about $10,734,000. Finally, D. E. Shaw & Co. Inc. acquired a new stake in Aurora Cannabis during the 4th quarter worth about $10,504,000. Hedge funds and other institutional investors own 9.00% of the company’s stock.

About Aurora Cannabis

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Read More: Cost of Capital

Get a free copy of the Zacks research report on Aurora Cannabis (ACB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Aurora Cannabis (NYSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aurora Cannabis and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts